First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

October 1, 2007

Last Updated Date

October 1, 2007

Start Date ^†

Current Primary Outcome Measures ^†

Original Primary Outcome Measures ^†

Change History

No Changes Posted

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Official Title ^†

Brief Summary

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum

Detailed Description

Study Phase

Study Type ^†

Interventional

Study Design ^†

Non-Randomized, Open Label, Single Group Assignment

Condition ^†

Colonic Neoplasms
Rectal Neoplasms

Intervention ^†

Radiation: First-Line Bevacizumab and Chemotherapy
Drug: Bevacizumab

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Active, not recruiting

Enrollment ^†

Completion Date

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria: - Patients with metastatic cancer of colon or rectum

Gender

Both

Ages

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00537901

Responsible Party

Secondary IDs ^††

Study Sponsor ^†

King Faisal Specialist Hospital & Research Center

Collaborators ^††

Investigators ^†

Principal Investigator:

Shouki Bazarbashi, MD

KFSH & RC

Information Provided By

King Faisal Specialist Hospital & Research Center

Verification Date

October 2007

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.